S. AREBEE, A. CRISPR Gene-Editing Therapies for Sickle Cell Disease and Beta- Thalassemia: Clinical Outcomes, Risks and Safety Profiles. A Systematic Review. Libyan Journal of Medical and Applied Sciences, [S. l.], v. 3, n. 4, p. 102–108, 2025. DOI: 10.64943/ljmas.v3i4.254. Disponível em: https://ljmas.com/index.php/journal/article/view/254. Acesso em: 23 jan. 2026.